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Summary
Barth syndrome (BTHS) is a rare X-linked recessive
disorder characterized by cardiac and skeletal myopa-
thy, neutropenia, and short stature. A gene for BTHS,
G4.5, was recently cloned and encodes several novel
proteins, named “tafazzins.” Unique mutations have
been found. No correlation between the location or
type of mutation and the phenotype of BTHS has been
found. Female carriers of BTHS seem to be healthy.
This could be due to a selection against cells that have
the mutant allele on the active X chromosome. We
therefore analyzed X chromosome inactivation in 16
obligate carriers of BTHS, from six families, using PCR
in the androgen-receptor locus. An extremely skewed
X-inactivation pattern (x95:5), not found in 148 fe-
male controls, was found in six carriers. The skewed
pattern in two carriers from one family was confirmed
in DNA from cultured fibroblasts. Five carriers from
two families had a skewed pattern (80:20–!95:5), a
pattern that was found in only 11 of 148 female con-
trols. Of the 11 carriers with a skewed pattern, the
parental origin of the inactive X chromosome was ma-
ternal in all seven cases for which this could be deter-
mined. In two families, carriers with an extremely
skewed pattern and carriers with a random pattern
were found. The skewed X inactivation in 11 of 16
carriers is probably the result of a selection against cells
with the mutated gene on the active X chromosome.
Since BTHS also shows great clinical variation within
families, additional factors are likely to influence the
expression of the phenotype. Such factors may also
influence the selection mechanism in carriers.
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Introduction
Barth syndrome (BTHS; MIM 302060) is a rare X-
linked inherited disorder characterized by cardiac and
skeletal myopathy, short stature, and neutropenia (Barth
et al. 1983). The gene was recently mapped to Xq28
(Bolhuis et al. 1991; Ade`s et al. 1993), and a novel gene,
G4.5, responsible for BTHS was cloned (Bione et al.
1996). BTHS is a severe disorder that is often fatal in
childhood and may be due to an acyltransferase defi-
ciency (Neuwald 1997). Unique mutations have been
reported (D’Adamo et al. 1997; Johnston et al. 1997).
BTHS has proved to be allelic to a lethal myocard dis-
order (Bleyl et al. 1997).
Female carriers of BTHS seem to have no symptoms
of the disorder, although a systematic clinical exami-
nation of carriers has not been reported. This could be
related to a nonrandom X chromosome inactivation. In
female mammals, one of the two X chromosomes in each
cell is inactivated in early embryonic life (Lyon 1961).
The inactivation is believed to be random, and most
females therefore have an ∼50:50 distribution of the two
cell populations. This is in agreement with the finding
of a mildly affected phenotype in many carriers of X-
linked disorders. However, in a number of severe X-
linked disorders, such as Wiskott-Aldrich syndrome
(WAS), a-thalassemia/mental retardation syndrome, and
Bruton X-linked agammaglobulinemia, female carriers
have a completely normal phenotype. Obligate carriers
of these disorders have skewed X chromosome inacti-
vation (Fearon et al. 1988; Gibbons et al. 1992; Allen
et al. 1994). This is presumably the result of selection
against cells with the X chromosome carrying the mutant
allele as the active X chromosome. X chromosome–
inactivation analysis therefore may be used in carrier
detection for these disorders. The X-inactivation pattern
in 20 carriers from six families with BTHS was analyzed
in order to identify a possible selection mechanism in
these families.
Subjects and Methods
Subjects
Blood samples were obtained from 20 carriers and
four noncarriers, from six BTHS families, after informed
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Figure 1 Pedigrees of families, as reported previously (family 1 by Barth et al. [1983]; family 2 by Ørstavik et al. [1993]; families 3, 4,
and 6 by D’Adamo et al. [1997]; and family 5 by Lindenbaum et al. [1973]). The X-inactivation pattern is indicated as a ratio, for informative
carriers. Age at death or present age is indicated for affected males.
consent. In all the families, a mutation in the BTHS gene
had been identified and confirmed in the carriers
(D’Adamo et al. 1997). All the families had unique mu-
tations, except families 5 and 6, which had the same
missense mutation in exon 10. The affected males from
these two families had a clinical picture of endocardial
fibroelastosis (EFE1). One family had a single carrier
only; the remaining families had 2–6 carriers (fig. 1).
The age at death or the age of the surviving male is
indicated in figure 1. In family 2, skin fibroblasts and
granulocytes were obtained from both carriers, in ad-
dition to blood. Further details of the families, including
the age of the carriers at the time of blood sampling, are
listed in table 1.
None of the carriers were known to have cardiac dis-
ease or short stature. The white-cell count was normal
in carriers IV-20 and IV-21 (Barth et al. 1983) and in
the two carriers from family 2. For the remaining car-
riers, a white-cell count was not available. Life expec-
tancy of BTHS carriers is not known, but the mother of
carriers III-1 and III-2 from family 1 was reported to be
alive at age 92 years. Blood was also obtained from 158
blood donors, aged 20–60 years.
DNA Isolation
Skin fibroblasts were subcultured in minimal essential
medium. Granulocytes were separated from whole
blood, and DNA was isolated from blood cells and fi-
broblasts, by standard procedures.
X Chromosome–Inactivation Analysis of the Androgen-
Receptor (AR) Gene
The X-inactivation pattern was determined by PCR
analysis of a polymorphic CAG repeat in the first exon
of the AR gene (Allen et al. 1992). Methylation of sites
close to this short tandem repeat has been found to cor-
relate with X chromosome inactivation. The site is meth-
ylated on the inactive X chromosome and therefore re-
sists cleavage by HpaII, and PCR products are obtained
from the inactive X chromosome only. The PCR prod-
ucts were separated on an ABI 373A automated se-
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Table 1
X Chromosome Inactivation in Females from BTHS Families
Family
and Carrier
Age at Blood
Sampling
(years) Reference Mutation X Inactivation
Origin of
Inactive X
1:
III-12 66 Barth et al. (1983) Y51X exon 2 Homozygous
IV-20 42 Y51X exon 2 17:83 Maternal
IV-21 39 Y51X exon 2 13:87 Maternal
IV-22 38 Y51X exon 2 15:85 Maternal
IV-27 33 Y51X exon 2 13:87 Maternal
IV-44 29 Y51X exon 2 Homozygous
2:
I-1 60 Ørstavik et al. (1993) F178I exon 6 5:95
II-1 35 F178I exon 6 95:5 Maternal
III-3 7 No mutation 82:18
III-4 4 No mutation 76:24
3:
I-1 35 D’Adamo et al. (1997) 428 del13 exon 2 195:5
4:
II-1 36 D’Adamo et al. (1997) G197R exon 8 76:24
II-2 34 G197R exon 8 73:27
5:
II-5 Lindenbaum et al. (1973) Misssense exon 10 56:44
II-7 Misssense exon 10 Homozygous
III-1 D’Adamo et al. (1997) Misssense exon 10 55:45
IV-1 Child Misssense exon 10 95:5 Maternal
IV-4 Misssense exon 10 Homozygous
III-8 No mutation 66:34
IV-10 Child No mutation 71:29
6:
II-1 75 D’Adamo et al. (1997) Missense exon 10 5:95
III-1 50 Misssense exon 10 195:5
III-2 47 Misssense exon 10 60:40
IV-4 18 Misssense exon 10 84:16 Maternal
quencer and were analyzed by GeneScan software (Ap-
plied Biosystems) (Pegoraro et al. 1994). X-inactivation
patterns were classified as random (ratio 50:50–!65:35),
moderately skewed (ratio 65:35–!80:20), skewed (ratio
80:20–!95:5), or extremely skewed (ratio x95:5).
X Chromosome–Inactivation Analysis of the
FMR1 Gene
X inactivation was also analyzed in one carrier, by
PCR of the FMR1 gene (Fu et al. 1991). The methylation
of the HpaII sites in the 5′ region of the FMR1 gene,
located upstream of the polymorphic GGC repeat, has
been found to correlate with inactivation of the X chro-
mosome. Quantitation of the results of the PCR-meth-
ylation assay was performed by use of phosphorimaging
analysis, as described elsewhere (Naumova et al. 1996).
Statistical Methods
The distributions of the X-inactivation pattern in the
BTHS carriers and the female controls were compared
by use of the Mann-Whitney test. The frequencies of the
extremely skewed X-inactivation pattern were compared
by use of Fisher’s exact test.
Results
The results of X-inactivation analysis of the carriers
are shown in table 1. Four of the 20 carriers were homo-
zygous for the CAG repeat at the AR locus and therefore
were not informative. In family 1, the four informative
carriers had an almost identically skewed pattern (15:
85) in the AR assay. However, the pattern in this family
was difficult to interpret, since the two alleles in all the
heterozygotes differed by one CAG repeat only. There-
fore, one carrier from this family also was tested in the
FMR1 assay, and an extremely skewed pattern (95:5)
was found. All four carriers had the maternally inherited
X chromosome, which carried the mutation, as the in-
active X chromosome.
In family 2, the two obligate carriers, I-1 and II-1,
had an extremely skewed pattern in the AR assay (fig.
2A). The skewed pattern in peripheral blood cells was
confirmed in DNA from granulocytes and cultured fi-
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Table 2
Distribution of X-Inactivation Pattern in BTHS Carriers and Female
Controls
X-Inactivation Pattern
No. (%)
of BTHS
Carriers
No. (%)
of Female
Controls
Random (50:50–!65:35) 3 (19) 81 (55)
Moderately skewed (65:35–!80:20) 2 (12) 56 (38)
Skewed (80:20–!95:5) 5 (31) 11 (7)
Extremely skewed (x95:5) 6 (38) 0 (0)
Total 16 148
NOTE.— (Mann-Whitney test).P ! .0001
Figure 2 X-inactivation analysis. A minus sign () indicates without HpaII predigestion, and a plus sign () indicates with HpaII
predigestion. A, Results for II-1 of family 2 (X-inactivation pattern, 95:5). B, Results for II-5 of family 5 (X-inactivation pattern, 56:44). C,
Results for a male control. Note the lack of PCR product after HpaII digestion.
broblasts. II-1 also had the maternally inherited X chro-
mosome as the inactive X chromosome. The two daugh-
ters of II-1, III-3 and III-4, lacked the mutation and had
a skewed and moderately skewed X-inactivation pattern,
respectively. In this family, therefore, the extremely
skewed X-inactivation pattern segregated with the mu-
tation. The only carrier from family 3 also had an ex-
tremely skewed X-inactivation pattern, whereas a mod-
erately skewed pattern was found in the two carriers,
II-1 and II-2, from family 4.
Families 5 and 6 included five and four informative
carriers, respectively. In these families, carriers with both
an extremely skewed X-inactivation pattern and a ran-
dom pattern were found. In skewed carriers IV-1 from
family 5 and IV-4 from family 6, the origin of the inactive
X chromosome was maternal.
The X-inactivation pattern was analyzed in the 158
female controls by use of the AR assay. Ten females were
not informative. Of the remaining 148 females, 55%
had a random pattern, 38% had a moderately skewed
pattern, and 7% had a skewed pattern (table 2). A sim-
ilar distribution previously had been found in 30 normal
females (Ørstavik et al. 1996b). No female in either sam-
ple had an extremely skewed X-inactivation pattern. The
difference between the distributions of the X-inactiva-
tion pattern in the BTHS carriers and the female controls
was highly significant ( ; Mann-Whitney test).P ! .0001
The finding of an extremely skewed X-inactivation pat-
tern in six carriers and in none of the female controls
also was highly significant ( ; Fisher’s exactP ! .00001
test).
Discussion
The X-inactivation pattern in the 16 carriers varied
both between and within the six families (table 1). An
X-inactivation pattern of 95:5 or more—as was found
in the six carriers from families 2, 3, 5, and 6—was not
found in any of 148 female controls. The X-inactivation
pattern in BTHS carriers therefore clearly differs from
that in female controls. Furthermore, a skewed pattern
was found in significantly more carriers than controls
(table 2).
The frequency of skewed X inactivation increases in
older females (Busque et al. 1996; Gale et al. 1997),
possibly owing to an X-linked gene that regulates he-
matopoietic stem-cell kinetics (Abkowitz 1998). How-
ever, of the six females with an extremely skewed X-
inactivation pattern, one was a child and two were
young females. Furthermore, although skewed carriers
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I-1 from family 2 and II-1 from family 6 were 60 and
75 years of age, respectively, at the time of blood sam-
pling, they both had daughters who also were extremely
skewed. The skewed pattern found in I-1 of family 2
also was found in cultured fibroblasts, in which age-
related increased skewing of X inactivation is not ex-
pected. The extreme skewing found in the six BTHS
carriers therefore is unlikely to be related to age.
A skewed X-inactivation pattern may be mainly due
to three different mechanisms (Puck and Willard 1998).
The most frequent cause of a skewed X-inactivation pat-
tern is a chance occurrence arising from the small num-
ber of cells at the time of X inactivation. This is a highly
unlikely explanation for the skewing in the BTHS car-
riers, both because of the large number of females with
an extremely skewed pattern, in this carrier population,
and because of the occurrence of more than one ex-
tremely skewed carrier in the same family.
A second possibility is a genetic influence on the pro-
cess of X inactivation in these families that acts inde-
pendently of the BTHS mutation. Many families—both
normal families and families with X-linked disor-
ders—have been reported to have more than one female
with a skewed X-inactivation pattern (Hoffman and Pe-
goraro 1995; Belmont 1996; Naumova et al. 1996;
Ørstavik et al. 1996a). Genetic factors are most likely
to influence the choice of which X chromosome will be
inactivated initially. Some females therefore will be pre-
disposed to skewing (Plenge et al. 1997).
A mutation in the XIST gene recently was reported
for a carrier of X-linked ichthyosis who had skewed X
inactivation (Plenge et al. 1997). This XIST minimal-
promoter mutation was found in only 1 of 1,166 in-
dependent X chromosomes studied. Therefore, this rare
mutation is unlikely to have occurred by chance in five
of six BTHS families. Furthermore, in all the families,
the extremely skewed X inactivation was found to be
associated with carrier status, since none of the four
females who were excluded as carriers had the extremely
skewed X-inactivation pattern. Therefore, a genetic
mechanism acting independently of the BTHS mutations
is not a likely explanation for the skewed X-inactivation
pattern in the carriers.
The most likely explanation for the skewed X in-
activation in the BTHS carriers is a postinactivation
selection mechanism (Migeon 1993). This implies a
growth disadvantage for the cells having the mutated
BTHS gene on the active X chromosome. Postinacti-
vation cell selection is expected to be restricted to a single
target tissue, as is found in WAS carriers, in whom the
skewed X inactivation is found in hematopoetic cells but
not in fibroblasts and buccal-smear cells (Fearon et al.
1988). In family 2, both carriers also were shown to
have a skewed pattern in cultured skin fibroblasts. How-
ever, since respiratory-chain abnormalities have been
found in cultured fibroblasts from BTHS patients (Barth
et al. 1996), the skewed pattern in fibroblasts is not in
conflict with a selection mechanism.
In family 1, all four carriers had a skewed pattern in
the AR assay, and one carrier had an extremely skewed
pattern in the FMR1 assay. In the four carriers, the X-
inactivation pattern was identical, and the maternal X
carried the mutation as the inactive X chromosome, in
most cells. Therefore, the pattern is likely to be related
to carrier status, and a selection is likely to have taken
place in family 1. Unfortunately, there were no noncar-
rier females available from this family, to confirm that
the skewed pattern segregated with the disorder. The
selection hypothesis is supported by the finding of a ma-
ternal origin of the inactive X chromosome in seven
carriers with skewed and extremely skewed X inacti-
vation. Family 4, however, in which both carriers had a
moderately skewed X-inactivation pattern, demon-
strates that an extremely skewed X inactivation is not
a general phenomenon in BTHS carriers.
The most striking finding of our study is the X-in-
activation pattern in families 5 and 6, in which both a
skewed and a random pattern were found. Affected
males in these two families had EFE1 and a GrA change
in exon 10, causing a GrR change in the sequence of
the protein (G240R) (D’Adamo et al. 1997). Of partic-
ular interest is the intrafamilial variation in affected
males in family 6. Although three patients from family
6 died in infancy, one patient (IV-2) survived and is now
normal at age 25 years. Another male (II-2) from this
family must have transmitted the gene to his daughter.
No further information on this male was available.
The phenotype of BTHS varies both between and
within families and cannot be explained by the nature
of the mutation alone (Christodoulou et al. 1994;
D’Adamo et al. 1997; Johnston et al. 1997). It therefore
has been suggested that additional factors modify the
expression of the BTHS phenotype. Such additional fac-
tors also may modify the selection mechanism in the
BTHS carriers. The function of the G4.5 gene is un-
known. The sequence of the tafazzins is highly con-
served, and, therefore, the tafazzins likely have impor-
tant functions. Since a few patients who survived the
disorder in childhood became healthy adults, the func-
tion of tafazzins appears to be substituted in later life.
One possible explanation for the presence of both a
skewed and a random X-inactivation pattern in BTHS
carriers may be a different degree of growth disadvan-
tage during early development. In some carriers, the
growth disadvantage of the cells with the BTHS muta-
tion on the active X chromosome may result in extreme
skewing. In other carriers, additional factors that modify
the expression of the BTHS phenotype also could modify
the growth disadvantage to such a degree that the se-
lective pressure is reduced or does not take place at all.
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The X-inactivation patterns in families 5 and 6 were
analyzed in DNA from peripheral blood cells only. The
possibility exists that the X-inactivation pattern in car-
riers with a random pattern may be skewed in other
tissues, such as fibroblasts, in which respiratory-chain
abnormalities have been found. Unfortunately, skin fi-
broblasts were not available from any of the carriers
from families 5 and 6.
To our knowledge, this is the first report of both a
very skewed and a random pattern of X inactivation in
unaffected carriers of an X-linked disorder. It would be
of interest to see if carriers with a random pattern differ
from carriers with an extremely skewed pattern—for in-
stance, by having minor signs of BTHS, such as shorter
stature and a lower white-cell count.
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